Company Filing History:
Years Active: 2006-2014
Title: The Innovative Contributions of Karen Da Silva
Introduction
Karen Da Silva is a prominent inventor based in Irvine, CA, known for her significant contributions to the field of ocular health. With a focus on treating retinal degenerative diseases, she has developed innovative methods that leverage hematopoietic stem cells. Her work has the potential to transform the treatment landscape for patients suffering from vision impairments.
Latest Patents
Karen Da Silva holds 3 patents that showcase her groundbreaking research. One of her latest patents is titled "Treatment of cone cell degeneration with transfected lineage negative hematopoietic stem cells." This method involves isolating a specific population of stem cells from the bone marrow and transfecting them with a gene that encodes an antiangiogenic fragment of human tryptophanyl tRNA synthetase. The transfected cells are then injected into the eye to inhibit the degeneration of cone cells, which are crucial for vision. Another notable patent is "Hematopoietic stem cells and methods of treatment of neovascular eye diseases." This patent describes isolated, adult bone marrow-derived stem cell populations that can rescue retinal blood vessels and neuronal networks, offering new hope for treating ocular vascular diseases.
Career Highlights
Karen Da Silva is affiliated with The Scripps Research Institute, where she conducts her research and develops her innovative treatments. Her work is characterized by a commitment to advancing medical science and improving patient outcomes.
Collaborations
Throughout her career, Karen has collaborated with esteemed colleagues, including Martin Friedlander and Atsushi Otani. These partnerships have enriched her research and contributed to the success of her innovative projects.
Conclusion
Karen Da Silva's contributions to the field of ocular health through her patents and research are invaluable. Her innovative approaches to treating retinal diseases highlight the importance of continued research and development in medical science.